NFE2L2 and diabetic kidney disease: In a previous study, AST increased Nrf2 nuclear translocation and enhanced the expression of NAD(P)H, NQO1, superoxide dismutase, and HO-1 in a high glucose-induced diabetic nephropathy injury model [25], indicating that the Nrf2 pathway may mediate AST’s protective effect [26].